MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1

Yingying Xu(Wannan Medical College), Huimian Xu(First Hospital of China Medical University), Lili Jiang(Dalian Medical University), Xiaoyu Zhang(Medizinische Hochschule Hannover), Zhi‐Feng Miao(Kaohsiung Medical University), Zhe Sun(Guangzhou University of Chinese Medicine), Feng Zhao(Tianjin Chest Hospital), Zhenning Wang(First Hospital of China Medical University), Yajuan Luo(China Medical University), Yongxi Song(First Hospital of China Medical University)
Oncogene
August 8, 2011
10.1038/onc.2011.340
Cited by 187

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Biomarkers of aging
|Science China Life Sciences|2023|362
Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis
|ACS Nano|2023|345